Bone Marrow Transplant Research Review, Issue 3

In this issue:

Use of busulfan in conditioning prior to allogeneic SCT
Prophylactic low-dose azacitidine post alloHSCT in AML and MDS
High-dose bendamustine and melphalan conditioning for ASCT in MM
VTD4 vs VTD6 induction in NDMM
American Society for Transplantation and Cellular Therapy recommendations on HCT in ALL
Fludarabine and TBI conditioning before haploidentical transplantation
Gene mutations and MRD-status predict relapse risk after alloHSCT in T-ALL
No benefit to upfront ASCT for DLBCL in first remission
ASCT is safe and efficacious in AL

Please login below to download this issue (PDF)